• Business Development
  • CSR
  • Adverse Event Reporting


Osteoporosis is the most common type of Bone disease which involves the risk of breaking a bone. Osteoporosis is a major global public health problem associated with significant morbidity, mortality, and socioeconomic burden.

Our body needs minerals calcium and phosphate to make and keep the bones healthy. A major risk is not having enough Calcium and Vitamin D3 through our food habits resulting in increased risk of fractures

Alkem understood the needs of the society and introduced Gemcal, our brand of Calcium Carbonate which became the No. 1 brand in its segment

  • We introduced Vitamin D3 in Soft Gelatin formulation- The Only brand manufactured as per US pharmacopoeia to meet vitamin D insufficiency associated with Osteoporosis, Osteoarthritis, Muscle pain & bone pain.
  • Vitamin D3 6 lac injection offers post fracture bone healing
  • We introduced Teriparatide in unique pen device with “Dial Back” option at an affordable and convenient anabolic therapy to reduce the need for costly surgical interventions caused by severe osteoporosis.
  • We increased patient compliance by giant strides with introduction of Zoledronic acid once a year injection for osteoporotic patients.
  • We have launched marine source Bioactive Collagen Peptides for treatment of chronic joint discomfort & progressive osteoarthritis which helps to regenerate cartilage & to improve movement flexibility.
  • We have various ongoing programmes for patients regarding early diagnosis and prevention of osteoporosis.
We are continuously working towards further new drugs for better osteoporosis treatment.